Arkadios Wealth Advisors Reduces Stake in Encompass Health Corporation $EHC

Arkadios Wealth Advisors reduced its stake in Encompass Health Corporation (NYSE:EHC) by 5.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,780 shares of the company’s stock after selling 463 shares during the period. Arkadios Wealth Advisors’ holdings in Encompass Health were worth $1,077,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. WPG Advisers LLC acquired a new position in Encompass Health during the first quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Encompass Health by 749.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after acquiring an additional 367 shares during the period. Park Place Capital Corp purchased a new stake in Encompass Health in the 2nd quarter valued at $72,000. Caitong International Asset Management Co. Ltd boosted its stake in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares during the period. Finally, SVB Wealth LLC purchased a new position in Encompass Health during the 1st quarter worth $84,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. KeyCorp upped their price target on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 16th. Bank of America upped their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Truist Financial increased their price target on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. Finally, Zacks Research upgraded shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. Two investment analysts have rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $142.86.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $113.86 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. The business’s fifty day moving average price is $124.22 and its two-hundred day moving average price is $118.99. The stock has a market cap of $11.47 billion, a PE ratio of 21.52, a price-to-earnings-growth ratio of 2.20 and a beta of 0.93. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The business had revenue of $136.30 million during the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is 14.37%.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.00% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.